Ann Romaker, MD
Sleep Medicine · Cincinnati, OHNPI 1386621548
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,310 of the $1,585 with a category attached, or 82.7%. It is spread thinly across 22 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for sleep medicine clinicians in OH, where the typical reported total is $1,549.
Across 58 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$323
- GSK$269
- Harmony Biosciences LLC$236
- Inspire Medical Systems, Inc.$202
- Baxter Healthcare$80
- Sanofi$57
- plus $418 from 16 others
What the payments were for
- Food & beverage$1,31083%
- Education$27517%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 8 | $323 |
| GSK | 14 | $269 |
| Harmony Biosciences LLC | 4 | $236 |
| Inspire Medical Systems, Inc. | 4 | $202 |
| Baxter Healthcare | 4 | $80 |
| Sanofi | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Fisher & Paykel Healthcare Inc | 3 | $46 |
| Philips North America LLC | 2 | $44 |
| Merck | 1 | $28 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $21 |
| United Therapeutics Corporation | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Alcresta Therapeutics, Inc. | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Pfizer | 1 | $16 |
| Inogen, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Itamar Medical Inc | 1 | $15 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$126
How this compares
$1,585 in reported general payments places this provider in the 50th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 36 | $649,692 |
| WakixPitolisant Hcl | 12 | $151,908 |
| Dupixent SyringeDupilumab | 20 | $71,265 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 79 | $64,355 |
| Dupixent PenDupilumab | 17 | $59,701 |
| Breo ElliptaFluticasone/Vilanterol | 41 | $31,308 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 56 | $30,289 |
| BelsomraSuvorexant | 39 | $26,990 |
| Incruse ElliptaUmeclidinium Bromide | 32 | $17,988 |
| Spiriva RespimatTiotropium Bromide | 16 | $16,079 |
| SunosiSolriamfetol Hcl | 12 | $14,723 |
| Spiriva HandihalerTiotropium Bromide | 27 | $14,693 |
| Modafinil | 93 | $13,217 |
| SymbicortBudesonide/Formoterol Fumarate | 40 | $10,939 |
| QuviviqDaridorexant Hcl | 17 | $7,943 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $236 | $151,90812 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $269 | $147,134223 claims |
| MerckBelsomra, Dulera | $28 | $31,58554 claims |
| Axsome Therapeutics, Inc.Sunosi | $18 | $14,72312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 94 sleep medicine providers in Ohio.
Other sleep medicine in Cincinnati
- Shahrokh JavaheriCincinnati$404K
- Anthony SuchoskiCincinnati$89K
- Shayla PullenCincinnati$71K
- Sunil DamaCincinnati$7K
- Omdevasena ThirugnanamCincinnati$7K
- Karthikeyan KanagarajanCincinnati$6K
- Chiranjeevi Pramodna SiddaguntaCincinnati$3K
- Bashar BrijawiCincinnati$3K
- Roma UyCincinnati$1K
- Asim RoyDublin$666K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.